Showing results (791-800 of 809) with videos related to

Sort By:
Pageof 81
Rheumatology (Oxford, England)|October 6, 2012
Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong ChinesePhilip Hei Li, Wilfred Hing Sang Wong, Tsz Leung Lee, et al.
Frontiers in Immunology|July 3, 2023
Risk and Factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patientsShirley C W Chan, Yong-Fei Wang, Desmond Y H Yap, et al.
Neurology|June 3, 2021
Clinical and Genetic Features in Patients With Reflex Bathing EpilepsyAndrea Accogli, Gert Wiegand, Marcello Scala, et al.
JAMA Internal Medicine|February 18, 2022
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical TrialSteven Chee Loon Lim, Chee Peng Hor, Kim Heng Tay, et al.
Brain : a Journal of Neurology|December 20, 2021
Forecasting stroke-like episodes and outcomes in mitochondrial diseaseYi Shiau Ng, Nichola Z Lax, Alasdair P Blain, et al.
Clinical Kidney Journal|March 24, 2025
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseasesJeffery C H Chan, Eugene Yu-Hin Chan, Samuel M S Cheng, et al.
Kidney International Reports|November 29, 2023
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney DiseasesDaniel Leung, Eugene Yu-Hin Chan, Xiaofeng Mu, et al.
ACS Central Science|June 2, 2021
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with RemdesivirHo Sing Lo, Kenrie Pui Yan Hui, Hei-Ming Lai, et al.
Allergy|March 8, 2026
Artificial Intelligence-Based Pathological Subtype Diagnosis of Nasal Polyps: A Multidimensional and Micro-Visualization StudyXin Luo, Hansheng Li, Jianning Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2026
Amivantamab Monotherapy in Chemorefractory <i>RAS</i>/<i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II StudyPaul E Oberstein, J Randolph Hecht, Kanwal Raghav, et al.
Pageof 81